HK1209359A1 - Use of megamonas hypermegale in the treatment or prevention of rheumatoid arthritis or related diseases - Google Patents

Use of megamonas hypermegale in the treatment or prevention of rheumatoid arthritis or related diseases

Info

Publication number
HK1209359A1
HK1209359A1 HK15110183.9A HK15110183A HK1209359A1 HK 1209359 A1 HK1209359 A1 HK 1209359A1 HK 15110183 A HK15110183 A HK 15110183A HK 1209359 A1 HK1209359 A1 HK 1209359A1
Authority
HK
Hong Kong
Prior art keywords
prevention
treatment
rheumatoid arthritis
related diseases
megamonas hypermegale
Prior art date
Application number
HK15110183.9A
Other languages
Chinese (zh)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1209359A1 publication Critical patent/HK1209359A1/en

Links

HK15110183.9A 2014-09-30 2015-10-16 Use of megamonas hypermegale in the treatment or prevention of rheumatoid arthritis or related diseases HK1209359A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410522288.9A CN104546938B (en) 2014-09-30 2014-09-30 Extremely huge Megamonas is treating or preventing the application in rheumatoid arthritis

Publications (1)

Publication Number Publication Date
HK1209359A1 true HK1209359A1 (en) 2016-04-01

Family

ID=53064710

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15110183.9A HK1209359A1 (en) 2014-09-30 2015-10-16 Use of megamonas hypermegale in the treatment or prevention of rheumatoid arthritis or related diseases

Country Status (2)

Country Link
CN (1) CN104546938B (en)
HK (1) HK1209359A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106980776B (en) * 2017-04-10 2019-05-24 重庆邮电大学 Gene family affiliation calculation method between a kind of species
US11160837B2 (en) 2017-09-15 2021-11-02 Bgi Shenzhen Megamonas funiformis and applications thereof
EP3808357A4 (en) * 2018-05-31 2022-02-16 BGI Shenzhen Composition and uses thereof
CN112888448B (en) * 2018-12-07 2023-07-25 深圳华大生命科学研究院 Use of megamonas simplex for preventing and/or treating metabolic diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040170617A1 (en) * 2000-06-05 2004-09-02 Finegold Sydney M. Method of treating diseases associated with abnormal gastrointestinal flora

Also Published As

Publication number Publication date
CN104546938A (en) 2015-04-29
CN104546938B (en) 2019-02-01

Similar Documents

Publication Publication Date Title
HK1209347A1 (en) Use of bacteroides dorei in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209365A1 (en) Use of bacteroides plebeius in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209360A1 (en) Use of bacteroides ovatus in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209350A1 (en) Use of bacteroides caccae in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209348A1 (en) Use of bacteroides thetaiotaomicron in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209349A1 (en) Use of parabacteroides merdae in the treatment or prevention of rheumatoid arthritis or related diseases
IL251526A0 (en) Use of cannabidiol in the treatment of tuberous sclerosis complex
ZA201607415B (en) Antibody-drug-conjugate and its use for the treatment of cancer
PL3157512T3 (en) Use of cannabidiol in the treatment of epilepsy
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
ZA201707303B (en) Compositions and methods for the treatment of immunodeficiency
IL254142B (en) Tradipitant for use in the treatment of a tradipitant-responsive disease or condition
PL3277280T3 (en) Isomyosmine for use in the treatment of autoimmune diseases
HK1209346A1 (en) Use of bifidobacterium bifidum in the treatment or prevention of rheumatoid arthritis or related diseases
GB201417163D0 (en) Substituted pyrimidine derivatives useful in the treatment of autoimmune diseases
PT3160464T (en) 6-hydroxybuspirone for use in the treatment of movement disorders
HK1209351A1 (en) Use of haemophilus parainfluenzae in the treatment or prevention of rheumatoid arthritis or related diseases
PT3177599T (en) Fumarate analogs and uses thereof in the treatment of an autoimmune disease or an inflammatory disease
HK1209359A1 (en) Use of megamonas hypermegale in the treatment or prevention of rheumatoid arthritis or related diseases
GB201404372D0 (en) Assay and treatment
HK1209363A1 (en) Use of lactobacillus crispatus in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209366A1 (en) Use of lactococcus lactis in the treatment or prevention of rheumatoid arthritis or related diseases
GB201522329D0 (en) Use of adjuvants for the prevention and/or treatment of autoimmune diseases
HK1246271A1 (en) Method for the synthesis of hydroxy-triglycerides and uses thereof for the prevention and treatment of diseases
HK1209357A1 (en) Use of dialister invisus in the treatment or prevention of rheumatoid arthritis or related diseases